A device for taking repeated biopsies of glioblastoma tumors
Official title: Tumor Monorail Device for Serial Glioblastoma Biopsy
Funded at Exvade Bioscience, INC. · NIH-11174633 · Data updated 2026-11-12
This study is testing a new device called the Tumor Monorail that helps doctors take safe and precise samples from glioblastoma tumors, making it easier to track how the tumor is changing and how well treatments are working, ultimately aiming to improve care for patients like you.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Exvade Bioscience, INC. NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | August 1, 2023 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $999,360 |
| NIH project number | 4R44CA285039-02 |
| Project ID | NIH-11174633 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with glioblastoma who require ongoing monitoring of their tumor status.
✕Less likely to help
Patients with non-glioblastoma brain tumors or those who are not undergoing treatment for glioblastoma may not benefit from this research.
What this research studies
This research focuses on developing the Tumor Monorail, a device designed to enable safe and accurate serial biopsies of glioblastoma tumors. By providing real-time access to tumor material, the device aims to improve the monitoring of tumor progression and treatment response, which is crucial for adjusting therapies to enhance patient outcomes. The approach involves leveraging established materials and designs that have been proven safe in clinical settings, ensuring reliability and biocompatibility. This innovative method seeks to address the limitations of current biopsy techniques and imaging methods that often fail to provide comprehensive insights into tumor behavior.
Why it matters
Potential benefit: If successful, this research could significantly improve the management of glioblastoma by allowing for timely adjustments to treatment based on accurate tumor monitoring.
How similar studies have gone: While the concept of serial biopsies is not entirely novel, the specific application of the Tumor Monorail device represents a new approach that has not been extensively tested in clinical settings.
Where this research is happening
-
Exvade Bioscience, INC.
Atlanta, United States Active
Researchers
- Principal investigator: Meehan, Sean — Exvade Bioscience, INC.
- Study coordinator: Meehan, Sean
Related research
Other NIH-funded projects on the same topics.
-
Small molecules to block Slit2/ROBO in glioblastoma
A study to test small molecule drugs that block Slit2/ROBO signals to help treat glioblastoma in patients.
-
Immunotherapy for glioblastoma: advancing treatment and understanding
A patient-friendly summary of a grant exploring new immune-based treatments for glioblastoma to improve options for people affected by this brain cancer.
-
Small-molecule and biologic treatments for glioblastoma using targeted brain delivery
A new approach aims to use FPS-ZM1 to shrink brain swelling and support immunotherapy for glioblastoma, potentially helping patients recover after surgery.
-
Targeted therapies for glioblastoma in adults and kids
A large NIH program is exploring new brain cancer therapies, including drugs that reach the brain and work against glioblastoma in both children and adults.
-
6-thio-2'-deoxyguanosine for glioblastoma: a new approach to target tumors before surgery
A trial tests a novel drug given before glioblastoma surgery to see how it behaves in the body and within the tumor, and to learn how it affects cancer cells and the immune environment.
-
CD38-Driven Changes in Brain Tumor Metabolism and Immunity in Glioblastoma
A patient-facing look at how scientists plan to study how glioblastoma grows by changing its metabolism and dampening the immune response, with potential targets to help treatment in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.